rosiglitazone has been researched along with Pancreatitis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, X; Guo, J; Li, S; Li, Y; Ma, X; Nie, S; Zhi, H | 1 |
| Cabay, RJ; Castellanos, KJ; Fantuzzi, G; Malecki, EA | 1 |
| Ji, K; Wang, H; Wang, R; Wu, X; Yan, Z; Zang, B | 1 |
| Chen, C; Feng, JR; Hao, SX; Wang, WX; Yan, H | 1 |
| Khanduja, KL; Malhotra, S; Pandhi, P; Sidhu, S; Vaiphei, K | 1 |
| Britti, D; Caputi, AP; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Thiemermann, C | 1 |
| Barthet, M; Closa, D; Folch-Puy, E; Granell, S; Iovanna, JL | 1 |
| Ince, P; Munir, A; Newell-Price, J; Ross, R; Song, F; Walters, SJ | 1 |
| Duan, SZ; Ivashchenko, CY; Mortensen, RM; Usher, MG | 1 |
| Elias, AN; Hofflich, H; Lizotte, P | 1 |
10 other study(ies) available for rosiglitazone and Pancreatitis
| Article | Year |
|---|---|
Inhibiting role of rosiglitazone in the regulation of inflammatory response and protective effects for severe acute pancreatitis in mice.
Topics: Animals; Ceruletide; Disease Models, Animal; Early Growth Response Protein 1; Female; Inflammation; Injections, Intraperitoneal; Interleukin-1beta; Interleukin-6; Mice; Mice, Inbred ICR; Pancreatitis; Protective Agents; RNA, Messenger; Rosiglitazone; Severity of Illness Index; Signal Transduction; Suppressor of Cytokine Signaling 3 Protein | 2019 |
Therapeutic administration of orlistat, rosiglitazone, or the chemokine receptor antagonist RS102895 fails to improve the severity of acute pancreatitis in obese mice.
Topics: Acute Disease; Animals; Anti-Obesity Agents; Benzoxazines; Interleukin-12; Interleukin-18; Lactones; Male; Mice, Inbred C57BL; Obesity; Orlistat; Pancreatitis; Piperidines; Receptors, CCR2; Rosiglitazone; Severity of Illness Index; Thiazolidinediones; Treatment Failure; Vasodilator Agents | 2014 |
Rosiglitazone attenuates renal injury caused by hyperlipidemic pancreatitis.
Topics: Acute Kidney Injury; Animals; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hyperlipidemias; Hypoglycemic Agents; Immunohistochemistry; In Situ Nick-End Labeling; Male; Pancreatitis; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones | 2015 |
[The effect of rosiglitazone on the activity of STAT1 in rats with severe acute pancreatitis].
Topics: Acute Disease; Animals; Disease Models, Animal; Male; Pancreas; Pancreatitis; Random Allocation; Rats; Rats, Wistar; Rosiglitazone; STAT1 Transcription Factor; Thiazolidinediones | 2009 |
Rosiglitazone promotes pancreatic regeneration in experimental model of acute pancreatitis.
Topics: Acute Disease; Animals; Arginine; Disease Models, Animal; DNA; Female; Male; Pancreatitis; PPAR gamma; Rats; Rats, Wistar; Regeneration; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Severity of Illness Index; Sincalide; Thiazolidinediones; Time Factors | 2011 |
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein.
Topics: Acute Disease; Amylases; Animals; Cell Adhesion Molecules; Ceruletide; Lipase; Lipid Peroxidation; Male; Mice; Pancreatitis; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors | 2004 |
Peroxisome proliferator-activated receptor gamma agonist reduces the severity of post-ERCP pancreatitis in rats.
Topics: Acute Disease; Animals; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Lipase; Liver; Male; NF-kappa B; Nitric Oxide Synthase Type II; Pancreatitis; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Severity of Illness Index; Thiazolidinediones | 2006 |
Ineffectiveness of rosiglitazone therapy in Nelson's syndrome.
Topics: ACTH-Secreting Pituitary Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Anti-Inflammatory Agents; Female; Fludrocortisone; Humans; Hydrocortisone; Hypoglycemic Agents; Magnetic Resonance Imaging; Male; Nelson Syndrome; Pancreatitis; Pituitary ACTH Hypersecretion; Pituitary Gland; Pituitary Neoplasms; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed | 2007 |
PPAR-gamma knockout in pancreatic epithelial cells abolishes the inhibitory effect of rosiglitazone on caerulein-induced acute pancreatitis.
Topics: Animals; Ceruletide; Chemokine CCL2; Intercellular Adhesion Molecule-1; Mice; Mice, Knockout; Pancreatitis; PPAR gamma; Proto-Oncogene Proteins c-jun; Rosiglitazone; Thiazolidinediones | 2007 |
Evidence of acute pancreatitis in a patient with radioresistant-differentiated thyroid cancer.
Topics: Female; Humans; Middle Aged; Pancreatitis; Peroxisome Proliferator-Activated Receptors; PPAR gamma; Radionuclide Imaging; Rosiglitazone; Thiazolidinediones; Thyroid Neoplasms; Treatment Failure | 2008 |